By Metro US
Posted on
KUALA LUMPUR (Reuters) – Malaysia on Monday signed a deal to buy an additional 12.2 million doses of a COVID-19 vaccine manufactured by U.S. and German drugmakers Pfizer and BioNTech, the health ministry said in a statement.
The deal brings the total amount of the Pfizer vaccines procured by Malaysia to 25 million doses, enough to cover 39% of its population, the ministry said.
(Reporting by Rozanna Latiff; Editing by Martin Petty)
Phillies Hold on in a Close One, Beating the Giants 5-4
Arsenal needs a favor from Tottenham in the title race. Current form suggests it won’t happen
It was a big week for Baltimore’s pitchers, including a couple just back from arm injuries
Cavaliers pull together to overcome Orlando, but challenge stiffens with top-seeded Celtics up next
Islanders star goalie Ilya Sorokin after 2023-24 struggles: ‘I’ll be back’
Sam Ash to close down for good after 100 years of business
82-year-old U.S. Sen. Bernie Sanders is running for reelection to a fourth term
Money isn’t enough to smooth the path for Republican candidates hoping to retake the Senate
A subset of Alzheimer’s cases may be caused by two copies of a single gene, new research shows
Columbia University cancels main commencement after weeks of pro-Palestinian protests
Many Florida women can’t get abortions past 6 weeks. Where else can they go?
With a vest and a voice, helpers escort kids through San Francisco’s broken Tenderloin streets
As the US moves to reclassify marijuana as a less dangerous drug, could more states legalize it?
Aetna agrees to settle lawsuit over fertility coverage for LGBTQ+ customers
